- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2026. Philstar Global Corp. All Rights Reserved
X
+ Follow ONCOLOGIC Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 267752
[Title] => Laparoscopic colorectal surgery
[Summary] => Few, if any, major surgical trials have caused as much of a stir as the Clinical Outcomes of Surgical Therapy (COST) study. The release of the long-awaited results in May marked the beginning of a new, minimally invasive age in colon cancer treatment.
The study showed conclusively that, in experienced hands, laparoscopic colectomy offers the same oncologic outcomes as the open procedure with shorter hospital stays and less postoperative pain. But the publication triggered as many questions as it answered about the future of colon cancer surgery.
[DatePublished] => 2005-01-09 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
ONCOLOGIC
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 267752
[Title] => Laparoscopic colorectal surgery
[Summary] => Few, if any, major surgical trials have caused as much of a stir as the Clinical Outcomes of Surgical Therapy (COST) study. The release of the long-awaited results in May marked the beginning of a new, minimally invasive age in colon cancer treatment.
The study showed conclusively that, in experienced hands, laparoscopic colectomy offers the same oncologic outcomes as the open procedure with shorter hospital stays and less postoperative pain. But the publication triggered as many questions as it answered about the future of colon cancer surgery.
[DatePublished] => 2005-01-09 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 9, 2005 - 12:00am
Recommended
The auditor-witness of the House prosecution testified yesterday that legitimate official receipts should be submitted to liquidate purchases of food and supplies using confidential funds, distinguishing them from mere acknowledgment receipts.
11 hours ago
The Commission on Audit deems Vice President Sara Duterte herself to be liable along with two others for P73.287 million in disallowed disbursements over just 11 days using the confidential funds of the Office of the Vice President.
1 day ago
A state auditor testified Tuesday, August 11, that several acknowledgment receipts for the Department of Education's confidential funds were issued on a single day across provinces from Abra to Agusan del Sur, even as only one officer was allowed to disburse the funds.
1 day ago
Commission on Audit supervising auditor Xylene Mae del Campo returns to the witness stand today at the Senate impeachment court, as she continues her testimony about the remaining audit of Vice President Sara Duterte’s confidential funds not covered by fellow COA auditor Roderick Wamil earlier.
3 days ago
Lotto Aug 12, 2026
EZ2/LVM - 22 6
SUERTRES - 6 9 6
4D Lotto - 0 0 0 0
6/45 Mega Lotto - 25 37 11 26 2 22
P15,000,000.00
6/55 Grand Lotto - 53 36 21 8 46 43
P128,414,048.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66








